MAP2K1 and gastric cancer: Inhibiting gastric cancer growth by competitive binding to MEK1, as the MAPK1-109aa expressed by circMAPK1, is one of the mechanisms by which it works to deactivate MAPK1 and its downstream components in the MAPK pathway [46].